SLANG Worldwide Inc.
$0.00+$0.00 (+47.62%)
SLANG Worldwide Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.2% below the high.
OTC · LAXAF · USD
Stock price, earnings
Quote as of Apr 5, 2023, 02:53 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Laxai Pharma, Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Laxai Pharma, Ltd. is an American company that offers specialized contract research services. The firm provides extensive support throughout the entire pharmaceutical development process. Its areas of expertise include biostatistics, various data management methodologies (such as electronic, hybrid, and paper-based systems), CDISC advisory, medical documentation, clinical trial monitoring, regulatory compliance, pharmacovigilance, and associated training initiatives. The company, which was initially named Nexgen Biofuels Ltd., officially adopted the name Laxai Pharma, Ltd. in February 2010. Its headquarters are located in Tampa, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:29 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$0.00+$0.00 (+47.62%)
SLANG Worldwide Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.2% below the high.
$0.01+$0.01 (+376.19%)
Rite Aid Corporation: Healthcare · Medical - Pharmaceuticals.
$0.07$0.00 (0.0%)
SugarBud Craft Growers Corp.’s quoted price sits in the lower half of its reported 52-week range, 77.44% below the high.
$1.16$0.00 (0.0%)
Evolva Holding S.A.’s quoted price sits in the lower half of its reported 52-week range, 32.16% below the high.
$0.00$0.00 (0.0%)
Medical Services International Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01-$0.01 (-68.71%)
Lotus Ventures Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.29% below the high.
$0.00$0.00 (0.0%)
FluroTech Ltd.: Healthcare · Medical - Devices.
$0.01+$0.01 (+100.0%)
Alseres Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.